Methods
This is a systematic review of randomised controlled trials of induction of labour at term for suspected fetal macrosomia. Suspected fetal macrosomia was defined as an ultrasonic estimated fetal weight > 4000g or ≥ 95 th centile. The primary outcome was caesarean delivery. RCTs looking exclusively at a population of women with pre-existing or gestational diabetes were excluded, but RCTs with some women with those conditions were included.
Findings
There was no significant effect on Caesarean delivery [relative risk (RR) 0.91, 95% confidence interval (CI), 0.76-1.09], operative delivery, shoulder dystocia, intracranial haemorrhage, brachial plexus palsy, low Apgar score, cord blood pH <7, or mean birth weight. The lack of effect on Caesarean section accords with other randomised trial of induction near term (1, 2).
The main benefit from induction was reduced fetal fractures (RR 0.17, 95% CI0.03-0.79). There were some harms from induction, hyperbilirubinemia (8.8% versus 2.9%; RR 3.03, 95% CI 1.60-5.74) and phototherapy (11.0% versus 6.6%; RR 1.68, 95% CI 1.07-2.66).
Commentary
This systematic review from BJOG is timely because in 2015 a large randomised trial, (DAME) (3) of 822 participants was published but was too small to draw firm conclusions. This systematic review includes the same trials, and draws similar conclusion to the updated Cochrane review on the same topic (4). The Cochrane review calculates the number needed to treat (NNT) to prevent one fracture as 60.
Although Magro-Malosso do not comment on it, there appeared to also be an adverse effect of perineal injury. In the largest study, third-and fourth-degree perineal tears were increased in the induction group (RR 3.70, 95% CI 1.04 -13.17). There is also a concern from observational studies that induction at early term gestations (37-38 weeks) may increase the risk of longer term developmental harm (5, 6) . Emerging evidence shows that gestational age may be best conceptualised as a continuum in which the risk of adverse neurodevelopmental outcomes increases with each decreasing week of gestation at birth, from 40 weeks gestation. Thus induction even as late as 39 weeks may have previously unforeseen impact on development.
Implications for practice
Unsurprisingly reviewers' interpretation of these data vary. Magro-Malosso concluded "induction of labour ≥38 weeks for suspected fetal macrosomia is associated with a significant decrease in fetal fractures, and therefore can be considered as a reasonable option."
The Cochrane review was more cautious concluding "although some parents and doctors may feel the evidence already justifies induction, others may justifiably disagree. Further trials of induction shortly before term for suspected fetal macrosomia are needed. Such trials should concentrate on refining the optimum gestation of induction, and improving the accuracy of the diagnosis of macrosomia."
